3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Stomach Neoplasms
2
Tracheal Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Peritoneal Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
HER2 Positive Esophagogastric Cancer
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma, Adenoid Cystic
1
Advanced Esophageal Cancer
1
Interventions
Capecitabine
20
Oxaliplatin
13
Irinotecan
8
spartalizumab
6
tislelizumab
4
Radiation
4
Neoadjuvant Therapy
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
sintilimab
2
camrelizumab
2
Radiotherapy
2
Leucovorin
2
Celecoxib
2
veliparib
1
peposertib
1
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Combined Modality Therapy
×
Gastrointestinal
×
Clear all
NCT03034473
2023-12-28
TransValid-A
University Medical Center Goettingen
Phase NA
Unknown
200 enrolled